Poniard Pharmaceuticals, Inc. is a biopharmaceutical company focused on the discovery, development.
Business Model:
Revenue: $0
Employees: 11-50
Address:
City: San Francisco
State: California
Zip:
Country: United States
Poniard Pharmaceuticals, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of innovative oncology products to impact the lives of people with cancer.
Contact Phone:
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
8/1/1988
Ticker Symbol:
NERX
IPO Price:
$7/share
Amount Raised:
$18M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 2/2006 | Post-IPO Equity | 5 | $65M |
Abingworth Bay City Capital Deepfield MPM Capital T. Rowe Price Abingworth Bay City Capital Deepfield MPM Capital T. Rowe Price |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|